They ask detailed questions about stomach problems like nausea, vomiting, belly pain, bloating, and feeling full quickly
This level of oversight ensures that patients stay committed to their goals, while providers can intervene and adjust care plans as necessary, optimizing patient outcomes
What You Should Know: A new report from Strata Decision Technology reveals a significant decline in the number of bariatric surgeries performed in U.S
Key Takeaways Tirzepatide is a dual agonist (GIP + GLP-1), approved by Health Canada under the brand names Mounjaro (type 2 diabetes) and Zepbound (obesity, sleep apnea)
Read more about GLP-1 drugs:
It is studied for helping the peptide attach better to cell membranes and interact with cell structures